Registration
Phase III clinical trials for Nav1.8 selective blockers have shown effective pain relief for both acute and neuropathic conditions without the side effects associated with opioids.
Phase III clinical trials for Nav1.8 selective blockers have shown effective pain relief for both acute and neuropathic conditions without the side effects associated with opioids.
Phase III clinical trials for Nav1.8 selective blockers have shown effective pain relief for both acute and neuropathic conditions without the side effects associated with opioids.